血液スクリーニングの世界市場：2024年

世界の血液スクリーニングの市場規模は近年力強く成長し、2023年に28億4,000万米ドルに達し、CAGR 10.0％で拡大し、2024年には31億3,000万米ドルに達すると予測されています。過去の期間に観察された成長は、輸血の需要の高まり、伝染性疾患の有病率の増加、政府の規制や基準の影響、献血や収集活動の増加、世界の健康への懸念やパンデミックなど、いくつかの要因に起因しています。

2023年の血液スクリーニング市場で最大の地域は北米でした。血液スクリーニング市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 血液スクリーニング市場の特徴

第3章 血液スクリーニング市場の動向と戦略

第4章 血液スクリーニング市場 - マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の血液スクリーニングの市場規模と成長

• 世界の血液スクリーニング市場の促進要因と抑制要因
  • 市場の促進要因
  • 市場の抑制要因
• 世界の血液スクリーニングの市場規模実績と成長、2018～2023年
• 世界の血液スクリーニングの市場規模と成長予測、2023～2028年、2033年F

第6章 血液スクリーニングの市場セグメンテーション

• 世界の血液スクリーニング市場、製品別セグメンテーション、実績・予測、2018～2023年、2023～2028年、2033年F
• 試薬・キット
• 器具
• ソフトウェア・サービス
• 世界の血液スクリーニング市場、技術別セグメンテーション、実績・予測、2018～2023年、2023～2028年、2033年F
• 核酸検査
• 酵素免疫測定法（ELISA）
• 迅速なテスト
• ウェスタンブロットアッセイ
• 次世代シーケンス（NGS）
• 世界の血液スクリーニング市場、エンドユーザー別セグメンテーション、実績・予測、2018～2023年、2023～2028年、2033年F
• 血液バンク
• 診断センター・病理研究所
• 病院
• クリニック
• 外来手術センター（ASC）

第7章 血液スクリーニング市場の地域・国別分析

• 世界の血液スクリーニング市場、地域別、実績・予測、2018～2023年、2023～2028年F、2033年F
• 世界の血液スクリーニング市場、国別、実績・予測、2018～2023年、2023～2028年F、2033年F

第8章 アジア太平洋の血液スクリーニング市場

第9章 中国の血液スクリーニング市場

第10章 インドの血液スクリーニング市場

第11章 日本の血液スクリーニング市場

第12章 オーストラリアの血液スクリーニング市場

第13章 インドネシアの血液スクリーニング市場

第14章 韓国の血液スクリーニング市場

第15章 西欧の血液スクリーニング市場

第16章 英国の血液スクリーニング市場

第17章 ドイツの血液スクリーニング市場

第18章 フランスの血液スクリーニング市場

第19章 イタリアの血液スクリーニング市場

第20章 スペインの血液スクリーニング市場

第21章 東欧の血液スクリーニング市場

第22章 ロシアの血液スクリーニング市場

第23章 北米の血液スクリーニング市場

第24章 米国の血液スクリーニング市場

第25章 カナダの血液スクリーニング市場

第26章 南米の血液スクリーニング市場

第27章 ブラジルの血液スクリーニング市場

第28章 中東の血液スクリーニング市場

第29章 アフリカの血液スクリーニング市場

第30章 血液スクリーニング市場の競合情勢と企業プロファイル

• 血液スクリーニング市場の競合情勢
• 血液スクリーニング市場の企業プロファイル
  • Abbott Laboratories
  • Grifols SA
  • Becton Dickinson and Company
  • F. Hoffmann-La Roche AG
  • bioMerieux SA

第31章 世界の血液スクリーニング市場の競合ベンチマーキング

第32章 世界の血液スクリーニング市場の競合ダッシュボード

第33章 血液スクリーニング市場における主要な合併と買収

第34章 血液スクリーニング市場の将来展望と可能性分析

第35章 付録

“Blood Screening Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on blood screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for blood screening? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The blood screening market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Product: Reagents and Kits; Instruments; Software and Services
• 2) By Technology: Nucleic Acid Testing; Enzyme-Linked Immunosorbent Assay (ELISA); Rapid Tests; Western Blot Assays; Next-Generation Sequencing (NGS)
• 3) By End User: Blood Banks; Diagnostic Centers and Pathology Labs; Hospitals; Clinics; Ambulatory Surgical Centers (ASCs)
• Companies Mentioned: Abbott Laboratories; Grifols S.A.; Becton Dickinson and Company; F. Hoffmann-La Roche AG; bioMerieux S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Blood screening involves the examination of blood, plasma, or blood components intended for transfusion or incorporation into blood-based products. This process aims to detect antibodies, tumor markers, disease-causing agents, or indicators of illnesses, and to assess the effectiveness of treatments.

The primary products used in blood screening include reagents and kits, instruments, software, and associated services. Reagents are compounds or substances enabling reactions crucial for detecting, measuring, or preparing components due to their biological or chemical activity. Kits, on the other hand, are test kits used in laboratory settings or in the field to identify specific compounds in a sample. Technologies utilized in blood screening encompass nucleic acid testing, enzyme-linked immunosorbent assay (ELISA), rapid tests, western blot assays, and next-generation sequencing (NGS). These screening methods find application in various healthcare settings such as blood banks, diagnostic centers, pathology labs, hospitals, clinics, and ambulatory surgical centers (ASCs).

The blood screening market research report is one of a series of new reports from The Business Research Company that provides blood screening market statistics, including blood screening industry global market size, regional shares, competitors with a blood screening market share, detailed blood screening market segments, market trends and opportunities, and any further data you may need to thrive in the blood screening industry. This blood screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blood screening market size has grown strongly in recent years. It will grow from $2.84 billion in 2023 to $3.13 billion in 2024 at a compound annual growth rate (CAGR) of 10.0%. The growth observed in the historical period can be attributed to several factors, including a heightened demand for blood transfusions, an increased prevalence of transmissible diseases, the influence of government regulations and standards, a rise in blood donations and collection efforts, as well as global health concerns and pandemics.

The blood screening market size is expected to see rapid growth in the next few years. It will grow to $4.72 billion in 2028 at a compound annual growth rate (CAGR) of 10.9%. Anticipated growth in the upcoming period can be attributed to several factors, including the development of healthcare infrastructure, the implementation of public health awareness programs, advancements in infectious disease diagnostics, and a continued emphasis on global health concerns and pandemic preparedness. Key trends expected in the forecast period encompass an increase in infectious diseases, the adoption of automation and efficiency measures, a rise in blood transfusion demands, a heightened focus on transfusion safety measures, and increased research efforts in pathogen detection methodologies.

The blood screening market is anticipated to experience growth driven by an increase in the prevalence of infectious diseases. The analysis of blood for specific antibodies against infectious agents aids medical practitioners in diagnosing and treating these diseases, preventing further transmission and spread. Notably, global statistics from October 2022 by the World Health Organization reveal approximately 1.6 million deaths worldwide due to tuberculosis in 2021, including 187,000 cases with HIV. Moreover, data from December 2022 indicates a rise in malaria cases to 241 million, resulting in 627,000 predicted deaths in 2020. These figures underscore the vital role of blood screening in addressing infectious diseases and highlight its contribution to market growth.

In the blood screening market, the increasing prevalence of chronic diseases is a significant driver of growth. Chronic diseases, manageable but not curable long-term conditions, necessitate precise blood compatibility matching for transfusions during medical treatments. The importance of blood transfusions is evident in managing various chronic conditions, including autoimmune diseases, hematological disorders, and cancers. Notably, projections from January 2023 by the National Library of Medicine indicate a substantial increase in the number of individuals aged 50 and older with at least one chronic condition, expected to reach 142.66 million by 2050. The rising prevalence of chronic diseases and the demand for compatible blood screening contribute significantly to the expanding blood screening market.

In the blood screening market, product innovation emerges as a prominent trend among major companies aiming to strengthen their market position. Focused on research and development, these companies introduce innovative solutions to enhance blood screening processes. An example is the POGO system by Intuity Medical, Inc., introduced in November 2021. This automatic blood glucose monitoring device utilizes 10-test cartridge technology, streamlining the process of lancing, collecting, and analyzing blood from the finger. With a rapid four-second countdown for displaying results, the POGO system eliminates the need for additional test strips and lancets, offering a user-friendly experience compared to traditional blood glucose meters. This emphasis on product innovation reflects the commitment of companies to advancing technologies in the blood screening market.

Prominent players in the blood screening market are strategically engaging in collaborations with major manufacturing companies to fortify their market positions. These strategic collaborations enable companies to form alliances with partners possessing the requisite expertise, transforming conceptual ideas into tangible outcomes. An illustrative example is the November 2023 announcement by Universal DX, a Spanish biotech company, regarding a strategic collaboration with Quest Diagnostics, a US-based medical laboratory company and diagnostic information services provider. The collaboration aims to enhance colorectal cancer screening in the US, with over 110 million eligible individuals. Quest Diagnostics plans to offer clinical laboratory services utilizing UDX's advanced colorectal cancer screening blood test, Signal-C, to physicians and patients across the US under the commercial agreement terms between UDX and Quest.

In December 2021 development, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical and diagnostic company, executed the acquisition of TIB Molbiol Group for an undisclosed amount. This strategic move by F. Hoffmann-La Roche AG is geared towards augmenting its capabilities in the rapid development of assays for emerging pathogens and potential health threats, particularly infectious diseases. TIB Molbiol Group, a diagnostics company based in Germany, specializes in blood screening for testing, life science research, and medical diagnostics. This strategic acquisition bolsters F. Hoffmann-La Roche AG's position in addressing evolving challenges in the diagnostic landscape.

Major companies operating in the blood screening market report are Abbott Laboratories, Grifols S.A., Becton Dickinson and Company, F. Hoffmann-La Roche AG, bioMerieux S.A., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Ortho Clinical Diagnostics Inc., Beckman Coulter Inc., Siemens Healthineers AG, GE Healthcare, DiaSorin S.p.A., Merck KGaA, PerkinElmer Inc., Bio-Techne Corporation, Roche Diagnostics GmbH, Danaher Corporation, Sysmex Corporation, Natera Inc., GenMark Diagnostics Inc., QIAGEN N.V., Hologic Inc., Luminex Corporation, Trinity Biotech plc, Fujirebio Inc., OraSure Technologies Inc., Immunetics Inc., Accelerate Diagnostics Inc., Cepheid Inc., T2 Biosystems Inc., Haemonetics Corporation, HTG Molecular Diagnostics Inc., Verax Biomedical Inc

North America was the largest region in the blood screening market in 2023. The regions covered in the blood screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the blood screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The blood screening market consists of revenues earned by entities by providing transcription mediated amplification (TMA) and real-time PCR. The market value includes the value of related goods sold by the service provider or included within the service offering. The blood screening market also includes sales of analyzer, photo colorimeter, flame photometer, hemoglobin meter, blood roller mixer, dry bath incubators, and differential blood counter. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Blood Screening Market Characteristics

3. Blood Screening Market Trends And Strategies

4. Blood Screening Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Blood Screening Market Size and Growth

• 5.1. Global Blood Screening Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Blood Screening Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Blood Screening Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Blood Screening Market Segmentation

• 6.1. Global Blood Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Reagents and Kits
• Instruments
• Software and Services
• 6.2. Global Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Nucleic Acid Testing
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Rapid Tests
• Western Blot Assays
• Next-Generation Sequencing (NGS)
• 6.3. Global Blood Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Blood Banks
• Diagnostic Centers and Pathology Labs
• Hospitals
• Clinics
• Ambulatory Surgical Centers (ASCs)

7. Blood Screening Market Regional And Country Analysis

• 7.1. Global Blood Screening Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Blood Screening Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Blood Screening Market

• 8.1. Asia-Pacific Blood Screening Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Blood Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Blood Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Blood Screening Market

• 9.1. China Blood Screening Market Overview
• 9.2. China Blood Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Blood Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Blood Screening Market

• 10.1. India Blood Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Blood Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Blood Screening Market

• 11.1. Japan Blood Screening Market Overview
• 11.2. Japan Blood Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Blood Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Blood Screening Market

• 12.1. Australia Blood Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Blood Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Blood Screening Market

• 13.1. Indonesia Blood Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Blood Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Blood Screening Market

• 14.1. South Korea Blood Screening Market Overview
• 14.2. South Korea Blood Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Blood Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Blood Screening Market

• 15.1. Western Europe Blood Screening Market Overview
• 15.2. Western Europe Blood Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Blood Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Blood Screening Market

• 16.1. UK Blood Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Blood Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Blood Screening Market

• 17.1. Germany Blood Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Blood Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Blood Screening Market

• 18.1. France Blood Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Blood Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Blood Screening Market

• 19.1. Italy Blood Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Blood Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Blood Screening Market

• 20.1. Spain Blood Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Blood Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Blood Screening Market

• 21.1. Eastern Europe Blood Screening Market Overview
• 21.2. Eastern Europe Blood Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Blood Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Blood Screening Market

• 22.1. Russia Blood Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Blood Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Blood Screening Market

• 23.1. North America Blood Screening Market Overview
• 23.2. North America Blood Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Blood Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Blood Screening Market

• 24.1. USA Blood Screening Market Overview
• 24.2. USA Blood Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Blood Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Blood Screening Market

• 25.1. Canada Blood Screening Market Overview
• 25.2. Canada Blood Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Blood Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Blood Screening Market

• 26.1. South America Blood Screening Market Overview
• 26.2. South America Blood Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Blood Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Blood Screening Market

• 27.1. Brazil Blood Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Blood Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Blood Screening Market

• 28.1. Middle East Blood Screening Market Overview
• 28.2. Middle East Blood Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Blood Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Blood Screening Market

• 29.1. Africa Blood Screening Market Overview
• 29.2. Africa Blood Screening Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Blood Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Blood Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Blood Screening Market Competitive Landscape And Company Profiles

• 30.1. Blood Screening Market Competitive Landscape
• 30.2. Blood Screening Market Company Profiles
  • 30.2.1. Abbott Laboratories
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Grifols S.A.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Becton Dickinson and Company
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. F. Hoffmann-La Roche AG
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. bioMerieux S.A.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Blood Screening Market Competitive Benchmarking

32. Global Blood Screening Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Blood Screening Market

34. Blood Screening Market Future Outlook and Potential Analysis

• 34.1 Blood Screening Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Blood Screening Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Blood Screening Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer